Manabu Yoshioka

757 citations
36 papers · 273 indexed · h-index 9
Topics
Drug-Induced Adverse Reactions (8 papers)Cutaneous lymphoproliferative disorders research (7 papers)Autoimmune Bullous Skin Diseases (4 papers)
Partner nations
Japan

In The Last Decade

Manabu Yoshioka

33 papers receiving 270 citations

Peers

Manabu Yoshioka
Comparison fields: 5 of 56
  • Immunology 110
  • Dermatology 110
  • Oncology 59
  • Pathology and Forensic Medicine 57
  • Ecology, Evolution, Behavior and Systematics 45
Replace Kentaro Yonekura with:
Kentaro Yonekura Japan
H Barrière France
Koji Ito Japan
Junichi Miyatake Japan
J L Verret France
Aslı Akın Belli Türkiye
Alina Jankowska‐Konsur Poland
S. Pérez‐Gala Spain
Roberto Cortés‐Franco Mexico
Sawako Nakachi Japan
Manabu Yoshioka relative to Kentaro Yonekura Japan Kentaro Yonekura's profile →
Citations per field
00.5×1.5×
Kentaro Yonekura · 1×
Citations per year

Countries citing papers authored by Manabu Yoshioka

Since Specialization
Citations

This map shows the geographic impact of Manabu Yoshioka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manabu Yoshioka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manabu Yoshioka more than expected).

Fields of papers citing papers by Manabu Yoshioka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manabu Yoshioka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manabu Yoshioka. The network helps show where Manabu Yoshioka may publish in the future.

Co-authorship network of co-authors of Manabu Yoshioka

This figure shows the co-authorship network connecting the top 25 collaborators of Manabu Yoshioka. A scholar is included among the top collaborators of Manabu Yoshioka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manabu Yoshioka. Manabu Yoshioka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 17
2 8
3 8
4 5
5 2
6 1
7 3
8 2
9 9
10 2
11 2
12 0
13 3
14 3
15 2
16 6
17 4
18 16
19 29
20 9

About Manabu Yoshioka

Manabu Yoshioka is a scholar working on Dermatology, Toxicology and Pharmacology, having authored 36 papers that have together received 273 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (8 papers), Cutaneous lymphoproliferative disorders research (7 papers) and Autoimmune Bullous Skin Diseases (4 papers). The work is most often cited by research in Dermatology (110 citations), Immunology (110 citations) and Pathology and Forensic Medicine (57 citations). Manabu Yoshioka has collaborated with scholars based in Japan. Frequent co-authors include Yu Sawada, Motonobu Nakamura, Shun Ohmori, Daisuke Omoto, Daisuke Nishio, Takashi Yamaguchi, Ryutaro Yoshiki, Kazunari Sugita, Takatoshi Shimauchi and Miwa Kobayashi. Their work appears in journals such as Blood, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026